Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control Study

SIMPLE SUMMARY: Growing evidence has reported the role of sorafenib in hepatocellular carcinoma (HCC) patients with liver transplantation (LT). However, the clinical impact of lenvatinib in this population is limited. Our study enrolled 10 HCC patients who received lenvatinib after LT in our institu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Yang, Chen, Chao-Long, Lin, Chih-Che, Wang, Chih-Chi, Liu, Yueh-Wei, Li, Wei-Feng, Chen, Yen-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469287/
https://www.ncbi.nlm.nih.gov/pubmed/34572811
http://dx.doi.org/10.3390/cancers13184584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469287/
https://www.ncbi.nlm.nih.gov/pubmed/34572811
http://dx.doi.org/10.3390/cancers13184584

Ejemplares similares